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Abstract: Health-related advertisements are aired daily on the radio in 
Ghana, many of them in local languages. However, little is known if these 
advertisements fulfill the conditions stipulated by the country’s authorities. 
This paper assesses the contents of six commercials in the Twi language on 
two radio stations - Adehyee FM and Hello FM - using the stipulations of 
Ghana Food and Drugs Authority (GFDA) as a guide. The English 
transcripts of the spot commercials were produced and analyzed within the 
relevant theoretical confines. The results show that none of them has fully 
aligned with the relevant rules and regulations as each recorded only a 50 
percent compliance rate during the investigation. To counter this challenge, 
a new stakeholder assessment model, that makes everyone in the value 
chain of advertisement production relevant, is proposed. 
Keywords: Advertisement, medication, health, gatekeeping, broadcasting, 
radio.  
 
Introduction  
Advertising can boost a company’s 
sales if it is well executed (Mckensey 
& Company, 2012). It is regarded as 
a necessity and has been adopted as a 
component of the marketing system 
in promoting products and services of 
which the pharmaceuticals and herbal 
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medicines are of note (Gellad et al., 
2007). Rules exist that guide or 
regulate the creation, production, and 
publishing or airing of commercials. 
The essence is to protect members of 
the public from unscrupulous 
advertising practices and exploitation 
that could have devastating 
consequences. In Ghana, every 
advertisement created and published 
follows the guidelines of the Food 
and Drugs Authority. This body 
regulates medical advertisements 
through the Public Health Act of 
2012 (Act 851) because medicines, 
by law, are not regarded as ordinary 
commodities (Barthes, 2014). Also, 
the Medicines Act Chapter 176 
(Sections 52 and 74) stipulates that 
no person can issue or publish any 
medical advertisement without first 
obtaining a permit from the licensing 
authority. One could also not alter 
any medical advertisement for which 
a permit has been granted (Health 
Sciences Authority, 2016). In some 
countries, unlike Ghana, herbal 
commercials display on-screen the 
permit details (Medical Board of 
Australia, 2009).  
Recently the body published more 
than 150 advertisements from six 
regions in Ghana which were non-
compliant from October 2017 to 
January 2018 in its FDA’s Hall Of 
Shame, 2018 (GFDA, 2018). Among 
them were medical products. While 
the body was applauded for 
identifying those advertisements that 
did not follow the rules (GFDA, 
2018) it received knocks for failing 
to provide the public with the details 
of how the advertisers fell short. This 
work exposes the issues related to 
non-compliant advertisements in 
Ghana, to create a fresh research 
trajectory that adds to the largely 
invisible literature on the subject. We 
assess six selected radio 
advertisements to test their 
conformity to the rules and 
regulations of the Ghana Food and 
Drugs Authority set criteria. A new 
model for assessing medical 
advertisements is also proposed.  
 
Objectives of the study 
The objectives of the study are the 
following: 
1. To examine the advertising 
content strategy of medical radio 
advertisements. 
2. To assess how compliant with 
the rules medical advertisements 
are, using the Ghana Food and 
Drugs Authority guidelines. 
3. To propose a framework for 
gatekeeping or regulating 
medical advertisements in sync 
with the Ghana Food and Drugs 
Authority guidelines. 
 
The rationale and significance of 
the study 
The rationale for this study is to 
expose researchers, advertisers, 
advertising agencies and radio 
stations to the content strategies of 
medical advertisers through the lens 
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of the Ghana Food and Drugs 
Authority. The study attempts to use 
the results from the assessment to 
elucidate the need to regulate medical 
advertisements, contrary to the desire 
of many advertisers who have 
personal interests to perpetuate over 
the public interest. This study is of 
importance to researchers who work 
in the area of medical 
advertisements’ content strategies 
especially on the grounds of how 
advertisers and advertising agencies 
try to outwit the regulatory bodies. 
To advertising agencies and 
advertisers that are ignorant of the 
requirements, this study attempts to 
enlighten them on the words and 
phrases that violate the set standards 
by the Ghana Food and Drugs 
Authority and the Medical Council of 
Ghana through a discursive approach. 
Lastly, it proposes a stakeholder 
framework for regulating the content 
of medical advertisements based on 
the findings of this research. 
 
Literature review 
Advertising plays a major role in 
modern healthcare in promoting 
better health practices and the 
availability of non-prescription 
medicines for better healthcare 
(World Self-medication Industry, 
2008). Scholars also affirm that 
pharmaceutical advertising has an 
important effect on the drug 
consuming behavior of patients. For 
instance, patients were eager to buy 
drugs after exposure to direct-to-
consumer advertising (Ghia, Jha & 
Rambhad 2014). These authors add 
that medical advertising has become 
a significant key player in shaping 
the attitude and behavior of people 
with attendant more purchase of 
drugs and visible return on 
investment in pharmaceutical 
production.  
Findings by the Prevention Magazine 
(2004) shows that 62.4 million 
patients talked to their doctors about 
advertised medicines and from these, 
16.2 million requested for an 
advertised medicine. Advertising, 
therefore, affects information 
seeking, health care visits and 
medicines inquiries from the doctor. 
Advertising of medicines is 
recognized as a potent tool for 
promotion but it must adhere to set 
health standards (Barthes, 2014; 
Kim, 2015). The set standards refer 
to guidelines for consumer 
advertising of health products in the 
category of non-prescription drugs, 
natural health products and medical 
devices in all media outlets (Ad. 
Standards, 2018). The coverage of 
medical advertisements may span 
across other areas such as medical 
treatment services, homeopathic 
medicines (Barthes, 2014) and more 
health disciplines based on the 
leadership capability of the 
authorities concerned.  
Advertisement in a medical context is 
any representation to promote 
directly or indirectly the sales of non-
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prescription drugs, natural health 
products and medical devices (Ad 
Standards, 2018; Spake & Joseph, 
2007). The essence of guidelines is to 
help the creators of advertising 
communications to understand the 
principles that govern health products 
promotion to help them develop 
messages that comply with the set 
standards (Ad Standards, 2018). It 
also prevents from circulating 
inferior commodities that can 
threaten the lives of the consumers 
especially in the case of oral 
substances (Barthes, 2014).  
Basically and universally, a medical 
advertisement should not be directed 
at children, avoid creating fear or 
apprehension and above all, be 
truthful and not misleading (World 
Self-medication Industry, 2008). The 
implication of all these is that 
medical advertisements cannot be 
treated as regular commercials even 
though the conventional commodity 
advertisements do follow ethical 
procedure. The consequences of 
wrongful medical advertisements are 
far weightier in terms of health risk 
implications.  According to the 
Ghana Food and Drugs Authority 
(GFDA, 2013), before any medical 
advertisement is published, it is 
compulsory for the advertisers and 
media owners to ensure that the 
content adheres to its 41 guidelines. 
In addition to the stipulations of the 
GFDA, the content of an 
advertisement is subject to the rules 
that guide the medium used for 
publishing it, as well as the general 
advertising guidelines for creating 
messages as enounced by the 
advertising practice regulators. With 
a loaded ecosystem of regulations, an 
advertisement may not be able to 
convey all the relevant information a 
patient needs in making a choice 
(World Self-medication Industry, 
2008).  
It is surprising that several articles 
published on medical advertisements 
have neglected the focus of study in 
this work, especially in the 
developing countries of West Africa, 
including Ghana. Such articles are 
usually pharmaceutically inclined, 
focusing mainly on analyzing drug 
claims, specifications and their 
authenticity and how all of these 
influence doctors’ prescriptions. 
(Randhawa et al., 2015). A few 
others focus on the impact 
pharmaceutical advertisements have 
on patient drug consumption 
behavior (Ghia et al., 2014) while 
some others analyze online videos, 
exploring whether or not the content 
of those videos drove away patients 
from good medical care (Muncy et 
al., 2014). This work attempts to 
provoke researchers' interest 
concerning the level of advertisers' 
compliance with regulations that 
guide the medical advertisements’ 
creation, strategy, and tactics.  
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Theoretical Model 
This study adopted the gatekeeping 
theory as a framework that served as 
a heuristic tool on which the 
assessment of the medical radio 
advertisement was carried out. 
Gatekeeping means exercising 
control over what information 
reaches the general public and how 
social reality is framed (Wallace, 
2018). Shoemaker & Vos (2009) add 
that in gatekeeping, information is 
facilitated or constrained based on 
the gatekeeper's preference, which is 
dependent on internal or external 
guidelines. Traditionally gatekeeping 
was more related to journalism but 
currently, the path has changed, as 
non-journalists actors are all involved 
in gatekeeping in different fields 
recently (Kommunikation, 2012). 
Gatekeeping is, therefore, not only 
for analyzing how news stories are 
censored. It is also deployed in many 
areas including field research 
(Barzilai-Nahon, 2008, 2009; 
Berente, Ivanov, & Vandenbosch, 
2010; Sturges, 2001). 
This work aligns with the linear or 
unidirectional approach in 
gatekeeping (Wallace, 2018). 
Medical advertising is subject to 
several controls to ensure that it 
complies with the rules of various 
bodies as a form of safeguard against 
the practices of unscrupulous 
advertisers and their agents.  
However, it is important to note that 
the framework of the gatekeeping 
theory is subjective, based on the 
selection and rejection criteria of the 
authorization body in context 
(Barzilai-Nahon, 2008) in this case, 
the GFDA. The subjectivity makes 
permissible censoring based on 
organizational structures and 
procedures, institutional 
environment, social environment, 
external and internal constraints as 
well as informational characteristics  
(Barzilai-Nahon, 2008). In the 
context of this study, the institutional 
environment specification which is 
the Ghana Food and Drugs Authority 
guidelines were used as the 
gatekeeping framework for censoring 
the medical radio advertisement as 
captured in Table 1 below.  
 
Research Method 
The qualitative research method was 
adopted in consonance with the aim 
of the research which was to assess 
the content of selected medical radio 
advertisements against the Food and 
Drugs Authority’s criteria, to check 
conformity as often demanded by 
scholars (Kaphingst, et al., 2004; 
Muncy et al., 2014 & Sözen,et 
al.,(2013). Here, we are looking 
specifically at how herbal medicine 
commercials have conformed to the 
rules and regulations of the Ghanaian 
authorities, represented by the 
GFDA.  The sample size was six. It 
was this fewer because the essence 
was not to quantify but to look at the 
content structure qualitatively closely 
regarding how advertisements have 
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been framed and how they follow the 
guidelines as set forth by the GFDA.  
Herbs are categorized as over-the-
counter medicines (Johns Hopkins 
Medicine, 2019).  Six Twi radio 
commercials were purposely selected 
from the 17 played on two radio 
stations Adehyee FM and Hello FM 
in Kumasi, Ghana. Their 
uncompliant tag made easier the 
purposive sampling. The 
commercials were first transcribed 
and then translated into English by a 
linguistic expert. The transcripts were 
analyzed using the Food and Drugs 
Authority criteria for medical 
advertisements. Permission was 
obtained from the radio stations to 
use the selected commercials. 
However, owing to the promise of 
confidentiality made by the 
researchers, the brands involved were 
anonymized and replaced with 
letters. Ten guidelines were selected 
from the GFDA’s 41 for over-the-
counter (OTC) medicines as shown 
in Table 1. 
 
Table 1: FDA guidelines for medical advertisements for Over-the-counter (OTC) 
medicines 
No  Guideline or Criteria 
1 No advertisement shall be framed in such a manner as to exploit the 
superstitious belief and/or induce fear in the consumer to purchase the 
product. 
2 No OTC drug advertisement shall over-dramatize any symptoms or signs. 
3 No OTC drug advertisement shall attack unfairly any competitive 
products, goods, and services.  
4 Advertisements for a product shall present information that is reasonably 
balanced between side effects and contra-indications and efficacy and 
safety. 
5 [OTC] advertising shall reflect an overall attitude of caution concerning 
drug usage, with emphasis on the rational use of medicines. It shall 
provide sufficient and balanced information to permit assessment of risk 
against the benefits. 
6 No advertisement for drugs shall contain any price, competition or similar 
scheme. 
7 No drug advertisement shall contain offers of gifts or refund of money to 
dissatisfied consumers. 
8 No OTC advertisement shall state or imply in absolute terms that OTC is 
‘safe’, ‘non-toxic’ or ‘has guaranteed efficacy’. 
9 OTC medicines including allopathic, food supplements, herbal and 
homeopathic, shall not be advertised for any of these diseases: 
Alcoholism, Appendicitis, Amenorrhoea, Arterio-Sclerosis (Strokes), 
Asthma, Blindness, Bladder Stones, Cancer, Convulsion, Deafness, 
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Diabetes, Diphtheria, Epilepsy, Diseases of the reproductive organ, 
Erysipelas, Fibroid, Gallstones, Goitre, Heart Disease, Hernia or Rupture, 
Hypertension, Infertility, Kidney Stones, Kidney Failure, Leprosy 
Leukemia, Systemic Lupus Erythematosis, Locomotortazy, Mental 
Disorders, Nephritis or Bright’s disease, Obesity, Paralysis, Pleurisy 
Pneumonia, Poliomyelitis, Prostate Diseases, Scarlet Fever, Septicaemia, 
Smallpox, Sexual Impotence, Tetanus or Lock-jaw, Trachoma and 
Tuberculosis. 
10 No OTC advertisement should imply superlative functions such as being 
the “drug of choice”, ‘the most frequently prescribed’, ‘the only drug for 
the purpose or that the drug has no side effects unless such claims can be 
adequately and scientifically substantiated. 
 
Findings and Discussions 
The transcripts for each commercial 
are presented before they are 
analyzed. Attentive listening to the 
commercials shows that the 
advertisers adopted both rational and 
emotional appeals. Each of them 
advances one reason or the other to 
attract patronage dramatically with 
male (MV) and female (FV) voice-
overs. Below are the six medical 
advertisements, the associated 
content analysis, and discussions. 
 
Advertisement No.1: 
“MV:  If a prophet had 
prophesied to me that a 
time would come for you to 
pamper me in this manner, 
I would not have believed 
it. 
FV:  Oh, when we used to fight, 
XXX Herbal Industries had 
not manufactured XXX 
capsules which you use 
now to show off.  
MV: Now that XXX capsules 
have been produced for 
men, we can now be active 
and get the strength to 
perform all works. 
FV: With the arrival of XXX 
capsules, you now sexually 
please me.  
MV:  Wow! XXX Herbal 
Industries have produced 
herbal medicines to cure 
serious and minor illnesses 
over thirty years now so if 
it has produced XXX 
capsules for men, we give a 
standing ovation. Only 
males above 18 years can 
take this medicine. It is 
available in all herbal, 
pharmacy and drug stores. 
…..  
FV: So now which of the foods 
would you like to eat first? 
MV:  is it what I have standing 
right in front of me. XXX 
capsules… 
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FV: show me your manly 
power.” 
 
When the first advertisement was 
assessed using the GFDA guidelines, 
we found that it had no issues with 
the induction of fear, attack on other 
products and showed no supremacy. 
It is also necessary to mention that 
the advertisement had funny lines 
which made listening to it interesting. 
All the six commercials had this 
character.  This Flipping the coin to 
the other side, four issues were 
identified: no caution was given in 
the usage of the product, and no side 
effects were mentioned. The ailment 
which it supposedly remedies was 
not mentioned! The last part of the 
advertisement which said: “So now 
which of the foods would you like to 
eat first? Is it what I have standing 
right in front of me” was over-acted 
and connotative with no straight 
meaning.  
Rather than mention the ailment, the 
commercial disguised it, apparently 
due to the prohibited advertisement 
for the implied health challenge, 
which is sex organ-related. It was 
constructed based on the logic of 
implication to get around a possible 
infringement as specified by GFDA. 
This is contrary to the rule that all 
advertisements should be 
comprehensible since a proper 
understanding and knowledge of the 
advertisement is connected to the 
purchasing intent of the product. 
Solomon et al. (2016) add that from 
the perspective of ethics and health, 
marketing communications should 
reflect the reality regardless of any 
advertising strategy. In this regard, 
the content must not use language or 
any device that can eliminate or 
shield the content of the 
advertisement to put the audience at 
peril. Concealing side effects is seen 
also in the findings of similar 
research (Chiou & Tucker, 2010), 
which disclose that advertisers do 
that just to increase patronage of their 
products by broadening the target 
audience through the elimination of 
side effects. 
 
Advertisement No.2: 
“FV: My love, honestly speaking 
you have made me happy 
today.  
MV: Oh my love, but this is just 
one. You’ll be pleased 
today. This is my little 
secret; it’s called XXX 
capsules. I recommend it 
for every man who wants to 
sexually please his wife, 
those suffering from waist 
pains and those with low 
sperm count. XXX capsules 
bring peace and happiness 
in marriages. 
FV:   A lady suffering from 
vaginal discharge and body 
odor can also be treated 
with YYY mixture.  
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MV: Men with shrink manhood 
due to the discharge of 
whitish fluids from their 
manhood, with the help of 
YYY mixture, there’s peace 
at home. Persons under 18 
years cannot take XXX 
capsules and pregnant 
women, lactating mothers 
or children under 12 years 
cannot take YYY mixture. 
…. 
The second advertisement complied 
with all the GFDA criteria except 
two. It did not mention the side 
effects of the advertised product. 
Concerning the OTC drugs that 
cannot be advertised (concerning 
some diseases), the content of the 
advertisement rather focused on the 
symptoms of a disease believed to be 
related to the reproductive organ and 
prescribed the product as potent for 
taking away those symptoms. The 
World Self-medication Industry 
(2008) notes that, though a piece of 
detailed information on a product can 
affect the recall potency, some 
advertisers intentionally leave such 
information (especially side effects) 
out because it may not sound 
attractive or may deter their 
prospective buyers. According to 
some authors (Othman, et al., 2010; 
Solomon et al., 2016), advertisers 
must bear in mind that the medical 
profession upholds high ethical 
standards in most climes. Thus, any 
drug marketing communication 
meant to inform the general public 
should show proof of standards, 
making sure that messages are 
honest, void of inaccurate 
expectations and respect the dignity 
of the medical profession.  
 
Advertisement No.3: 
MV: Madam, please stir the 
soup, bring up the fishes 
underneath and add the 
fishes to the ‘fufu’ for me.  
FV: Hi, gentleman, you are 
very interesting. 
MV:  I had malaria last three 
days which made me lose 
appetite. I nearly died. If 
I’ve been able to cure this 
malaria with XXX and 
XXX, I have to eat to my 
satisfaction. 
FV: Aaah, so you bought and 
took XXX and XXX? 
MV:  That’s what saved me! 
FV: Then you’re right. I didn’t 
know. Medicines 
manufactured by XXX 
Herbal Industries are 
very good. 
MV: Aaaahh, so you know. 
FV:    If not for XXX which 
cures malaria fever, 
vomiting, and headache, 
food vendors like me 
would not be able to do 
this job.  
MV: Yes it is true that XXX 
cures body weakness and 
loss of appetite 
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FV: Aaah, have your food. 
I’ve added more to it. 
MV: Well done. 
FV: Hey XXX, come for the 
food and serve him. 
MV: Ohh, thank you very 
much. 
FV: Everyone should purchase 
some….  
 
The third commercial complied with 
seven criteria. This is good news, 
taking into consideration the 
stringent nature of the criteria. The 
three not complied with were lack of 
information on side effects, no 
visible caution on the usage of the 
drug while facts related to the safety 
of the drugs were non-existent. It 
rather stressed that herbal medicine is 
very good which is seen in the 
comment: “Then you’re right. I 
didn’t know. Medicines 
manufactured by XXX Herbal 
Industries are very good…Everyone 
should purchase some….” This 
statement implies in absolute terms 
that the efficacy of the medicine is 
guaranteed. GFDA prohibits such 
lines because the medicine does not 
have (or does not provide) any 
scientific proof to justify the claim. 
This practice, if not curtailed or 
stopped, can affect the credibility of 
OTC drugs, with a concomitant 
effect on consumers' trust and 
ultimately on purchase. 
 
Advertisement No.4: 
MV: Please let me check your 
bag. 
FV: Young man, why? Again? 
MV: Hi! I told you to take just a 
bottle of XXX and you took 
three. 
FV: Young man, XXX has helped 
my household and me so 
there’s no way one will be 
enough. 
MV: For this, you deserve to take 
them. 
FV: If I’m to testify about XXX, it 
will take me to heaven. So, to 
cure malaria, use XXX. 
MV: That's not all. XXX is also 
recommended for persons 
who have lost appetite. 
Pregnant women, lactating 
mothers, and children below 
12 years cannot take in this 
medicine. …  
FV: Remember that the XXX. 
XXX, malaria fever will 
never be a part of your life. 
 
The fourth advertisement scored 
eight out of the ten criteria. No 
mention was made of the drug’s side 
effects while the caution that asks the 
target audience to consult a doctor 
should the symptoms persist is 
missing. The advertisement was clear 
in terms of its purpose concerning the 
associated ailment as heard in the 
statements: “So, to cure malaria, use 
XXX. XXX is also recommended for 
persons who have lost appetite.” 
However, some lines of the 
commercial are immaterial as they 
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appealed to emotion abstrusely and 
could probably have had some 
esoteric motive with people of 
immoral behavior in advertisers' 
minds. For instance, the statement “it 
will take me to heaven” overacts the 
potency of the drug and exaggerates 
the benefits derivable from it.  
 
Advertisement No.5: 
FV: Landlord, why don’t you 
knock before entering my 
room? What do you want 
at this time of the night, 
do you want to rape me? 
MV:    Don't say that because 
you are not in my size. My 
wife told me that XXX 
which you asked me to 
buy can cure bad odor.  
FV: Yes, it is true. XXX is 
good for someone who 
urinates frequently, whose 
heart beats very fast and 
a person with 
elephantiasis. It also 
burns fat in the human 
body, cures drowsiness 
and constipation. 
MV: XXX can be purchased 
XXX and at any drug 
store and herbal shop. 
FV: Take note, pregnant 
women, lactating mothers 
and children below 12 
years cannot take this 
medicine…. 
MV:    Honestly, XXX is very 
good medicine.  
FV: Say it again. 
 
The fifth advertisement did not meet 
the criteria on the exposure to the 
side effects of the medicine. It also 
did not touch on what one should do 
in case the symptoms persist. What's 
more, the commercial did not make 
any categorical statements on the 
nature of the disease it wanted to 
cure. Even the lines on symptoms 
were shilly-shallied as they vacillated 
from one to another, which made it 
rather difficult for a target audience 
to comprehend owing to the wide 
array. This flouts the GFDA rules. 
 
Advertisement No.6: 
FV: Mr. XXX, is it true XXX 
medicine can make a child 
brilliant? 
MV: It is true. Why do the whites 
hail him as XXX? The 
medicine produced by XXX 
can make a dull child very 
brilliant. Those who didn't 
believe it are now the ones 
broadcasting information 
about this medicine. The 
name of the medicine is XXX, 
also called "XXX”. Just buy 
one for your child who does 
not perform well in school 
and try it. If the child takes 
XXX or “XXX” medicine, it 
will make his brain very 
sharp. Since the introduction 
of this medicine, it has never 
failed anyone. Meanwhile, 
it’s not meant for children 
only. An adult can easily 
    11 
     11 
    Ginn Bonsu Assibey, et al                                                                                     CJOC (2019) 6(1) 1-18 
 
 
URL: http://journals.covenantuniversity.edu.ng/index.php/cjoc 
 
forget what he or she said; 
he may be holding something 
and still be looking for that 
thing. For those whose 
brain’s performance has 
reduced due to stroke can 
make their brain very sharp 
if they take in XXX or “XXX” 
medicine. You know 
everything about XXX or 
XXX is wonderful…. 
The sixth advertisement had many 
compliant challenges. It complied 
with three criteria regarding the 
consumers’ reception of the 
information. It could not meet seven 
other criteria which are so crucial. 
First, is that it overacted the targeted 
relief promised by the commercial 
contrary to the GFDA rule. “The 
medicine produced by XXX can make 
a dull child very brilliant,” The use 
of the word “very” is proof of this 
dramaturgic presentation. The 
advertisement did not highlight the 
side effects of the medicine. Neither 
did it caution the target audience on 
its indications and contra-indications. 
The statement “It is true. That’s why 
the whites hail him as XXX” 
exploited the audience by making it 
believe that it is white to be right - 
that the medicine hailed by the white 
people is approved. The 
advertisement also contained some 
over-acting. The line “For those 
whose brain’s performance has 
reduced due to stroke can make their 
brain very sharp if they take in XXX 
medicine” is a case in point. The line 
“Since the introduction of this 
medicine, it has never failed 
anyone.” implies supremacy which is 
also prohibited by the GFDA, more 
so when it did not provide any 
scientific proof. Medics and 
corpsmen think such advertisements 
do ridicule their professions. 
 
Summary of findings 
1. All six commercials did not 
fully comply with the rules set 
by the GFDA and averagely the 
compliance rate hovers around 
50 percent if it were 
quantitatively assessed. 
2. The six commercials adopted 
both rational and emotional 
appeals (Terkan, 2014) to attract 
patronage. While they provide 
some reason, all the six also 
adopted anecdotal but funny 
lines that make listening to 
delightful, as noted by Stern 
(1996). The commercials were 
nice to listen to for those who 
understand and speak the Twi 
language. 
3. It turned out that no visible 
information on drugs' side 
effects was the biggest criterion 
flouter. 
4. Most of the commercials did not 
mention the name of the disease 
to outwit the GFDA. Rather, 
they concentrated on the 
symptoms and left the audience 
to deduce the target ailment and 
then patronize the drug 
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5. Cautions on the usage of the 
products were invisible in most 
of the six commercials assessed.  
6. It appears this shortcoming is an 
indication that more gatekeeping 
measures are needed on medical 
advertisements to prevent abuse 
and safeguard consumers. 
 
Conclusion 
The about - 50 percent compliance 
notwithstanding, it is visible that 
advertisers and their agents are less 
circumspect in their advert placement 
on the radio. It is surprising that their 
commercials omitted side effects in 
the content published and were 
dangerously silent on whether or not 
the audience should consult a doctor 
in case the symptoms persisted after 
some specified days of using the 
medication. This silence is an 
infringement on the right of the 
audience to know. Some of these 
advertisements claimed supremacy 
while gimmicks were used to sway 
potential buyers to the counters. The 
consequences of this infringement on 
the buying public can be 
overwhelming, as noted by Ghia, Jha 
and Rambhad (2014), who affirm 
that pharmaceutical advertising has 
effects on the drug consumers’ 
behavior. One of these is that patients 
may end up buying medical products 
that do not resolve their health issues, 
thereby compounding their problems. 
The implication, therefore, is that 
need exists for a better assessment 
system for commercials before they 
are aired. This non-compliance issue 
is probably not an indication that the 
GFDA is inefficient. In fact, 
according to records, the body halted 
the airing of six commercials. The 
products concerned were recalled 
from the market 
(www.ghanaweb.com, 2018). 
Buoying up the capacity of GFDA 
financially and recruiting more staff 
for its monitoring operations can 
increase its efficiency.  
It is reasonable to suggest that GFDA 
needs some rejigging, but more 
importantly, it is the need for a 
framework that can avert the 
consequences that advertisements' 
non-compliance with the rules brings. 
The proposed framework makes all 
the stakeholders in the value chain of 
advertisement production responsible 
and liable. The advertiser, the 
advertising agency and the media 
house that publishes or airs the 
commercial are asked to use the 
guidelines of the GFDA as the 
gatekeeping mechanism in the value 
chain. It begins with a brief from the 
advertiser. Here, he instructs his 
agency to produce or craft the copy 
within the remit of what the 
authorities want. In the conception, 
production and publishing 
ecosystem, each of these biotic 
members – advertiser, advertising 
agency and media house – functions 
with due reference to the abiotic 
factors, which in this case are mainly 
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the stipulations of the GFDA.  The 
brief from the advertiser will reflect 
the rules, ditto the production of the 
commercials and their airing of the 
same. Succinctly: 
- The advertiser dictates the brief 
based on the FDA guidelines  
- The advertising agency produces 
the commercial from the brief in 
consonance with the FDA 
guidelines 
- The radio station or the media 
house air or publishes the 
commercial also using the GFDA 
guidelines.  
This means that the entire 
triangulated sequence starts and ends 
with obedience to the GFDA rules. 
This is different from the previous 
system where the application of 
GFDA rules starts and ends only with 
the media house. This sequence 
makes all the stakeholders not only 
responsible but also liable. 
 
 
Figure 1: The advertiser-agency-media house gatekeeping sequence for broadcast 
commercial   
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Suggestions for Further Studies    
1. This research covered only radio medical commercials and limited 
samples. For further research, a study can be conducted on a medical 
television commercial and print advertisements to check compliance with 
the Food and Drugs Authority guidelines.  
2. More importantly, there is also a need to assess the knowledge of the 
Food and Drugs Authority guidelines among the advertisers, the 
advertising agency and media houses personnel to help understand the 
challenges they have in engaging those guidelines in their professional 
activities. 
3. Advertising agencies and radio stations should also be educated on the 
Ghana Food and Drugs Authority guidelines especially on the need to 
adhere to the required standards at their end as part of their gatekeeping 
policies through workshops and conferences. 
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